First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration

Purpose: To assess the morphological and functional outcomes within the first year of treatment with intravitreal brolucizumab for refractory neovascular age-related macular degeneration (nAMD). Methods: This retrospective study included 21 eyes from 19 patients with refractory nAMD followed for 12 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdin, Alaa Din, Aljundi, Wissam, El Jawhari, Khalil, Suffo, Shady, Weinstein, Isabel, Seitz, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197757/
https://www.ncbi.nlm.nih.gov/pubmed/35721125
http://dx.doi.org/10.3389/fphar.2022.860784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197757/
https://www.ncbi.nlm.nih.gov/pubmed/35721125
http://dx.doi.org/10.3389/fphar.2022.860784

Ejemplares similares